Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center, posted on X:
“SMAC Mimetics/IAP antagonist in myeloid malignancies. British Journal of Haematology.”
Title:Â SMAC Mimetics as Potential Cancer Therapeutics in Myeloid Malignancies
Authors:Â Prajwal Boddu, Bing Z. Carter, Srdan Verstovsek, Naveen Pemmaraj
Read The Full Article at British Journal of Haematology.
More posts featuring Naveen Pemmaraju.